Assistant Professor David Olson has received the American Society for Neurochemistry’s Jordi Folch-Pi Memorial Award. The award is given to an outstanding young investigator who has demonstrated a high level of research competence and originality, has significantly advanced our knowledge of neurochemistry, and shows a high degree of potential for future accomplishments.
The growing popularity of microdosing — taking tiny amounts of psychedelic drugs to boost mood and mental acuity — is based on anecdotal reports of its benefits. Now, a study in rats by researchers at the University of California, Davis, suggests microdosing can provide relief for symptoms of depression and anxiety, but also found potential negative effects.
A team of scientists at the University of California, Davis, is exploring how hallucinogenic drugs impact the structure and function of neurons — research that could lead to new treatments for depression, anxiety and related disorders.
Alexandra Greb, a UC Davis senior in pharmaceutical chemistry from Danville, California, is a co-author on a new study exploring how hallucinogenic drugs affect the structure and function of neurons. The research could lead to new treatments for depression, anxiety and related disorders.
